The Impact of a Pharmacist's Participation on Hospitalists' Rounds
Authors:
- 1 February 2010
- journal article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 45 (2) , 129-134
Abstract
Background: Expanding the role of pharmacists in the hospital setting has the potential to positively impact the quality of patient care and provide cost savings. Previous studies have shown that integrating pharmacists into rounding teams can enhance patient care through interventions at the point of assessment and prescribing. This study examines these potential benefits at a community hospital that does not have formal hospitalist rounds and in which the pharmacists must make recommendations via written communication. Objective: The primary objective was to identify the number of interventions and to determine how to optimally utilize a pharmacist for a group of 19 hospitalists. Secondary objectives included estimating pharmacist time invested and cost savings. Methods: Initially, methods in this study included reviewing patient medication profiles and informally rounding with the hospitalists. Interventions were performed at the time of rounding. After 2 weeks of rounding, methods were altered to improve the efficiency of the pharmacist's time. Patient profiles were reviewed and interventions were performed by written communication. Results: A total of 386 patients were reviewed, with 117 interventions discovered. Fifty-eight verbal interventions were made during rounds with a 93% acceptance rate. Fifty-nine written interventions were made in the second part of the study with a 76% acceptance rate. The pharmacist spent an average of 10 minutes reviewing each patient profile, which resulted in a savings of $16 per hour of time invested. An actual cost savings of $3,900 was produced by 64 of the interventions, and the potential cost savings of the remaining 53 interventions exceeded $100,000. Conclusion: Opportunities for pharmacist interventions exist within a hospitalists' team and the potential benefits to patient care, along with the actual and potential cost savings, should justify creating collaborations between pharmacists and hospitalists.Keywords
This publication has 10 references indexed in Scilit:
- ASHP–SHM Joint Statement on Hospitalist–Pharmacist CollaborationAmerican Journal of Health-System Pharmacy, 2008
- Impact of a Pharmacy Resident on Hospital Length of Stay and Drug-Related CostsAnnals of Pharmacotherapy, 2007
- Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndromeAmerican Journal of Health-System Pharmacy, 2006
- Clinical Pharmacists and Inpatient Medical CareArchives of internal medicine (1960), 2006
- Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine UnitsArchives of internal medicine (1960), 2003
- Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- A Prospective, Randomized Trial to Assess the Cost Impact of Pharmacist-Initiated InterventionsArchives of internal medicine (1960), 1999
- Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication ErrorsJAMA, 1998
- Adverse Drug Events in Hospitalized PatientsExcess Length of Stay, Extra Costs, and Attributable MortalityJAMA, 1997
- The Costs of Adverse Drug Events in Hospitalized PatientsJAMA, 1997